Abstracts
Showing 852 abstracts.
Citation
Ethel D. Weld, Milena Boczar, Grace Montepiedra, Paula Britto, Diane Costello, Jack Moye, Pauline Howell, Louvina van der Laan, Rebecca Dirschberger, Nicole Macagna, Elin M. Svensson, Anthony Garcia-Prats. Pharmacokinetics and Safety of Delamanid and Optimized Background Regimen (OBR) in Children with Rifampicin-resistant Tuberculosis (RR-TB) with and without HIV (IMPAACT 2005).Study
IMPAACT 2005
Citation
Kristina Brooks, Jennifer Kiser, Pearl Samson, Yasha Rani, Shawn Ward, Timothy Cressey, Haseena Cassim, Jaime Deville, Gaerolwe Masheto, Ponego Ponatshego, Anne Coletti, Kathryn Lypen, Iris Mustich, Barbara Heckman, Mark Lojacono, Rachel Bowman, Dwight Yin, Ellen Townley, Sai Majji, Edward Acosta, Annie Buchanan, Cindy Brothers, Hardik Chandasana, Helena Rabie, Patricia Flynn, IMPAACT 2019 Team. Pharmacokinetics and Safety of Dispersible and Immediate Release FDC Abacavir/ Dolutegravir/ Lamivudine in Children with HIV Weighing =14 kg: Preliminary Results from IMPAACT 2019. Presented at: IAS 2021; 2021 Jul 17.Conference
IAS 2021
Study
IMPAACT 2019
Citation
Kristina Brooks, Jennifer Kiser, Pearl Samson, Yasha Rani, Shawn Ward, Timothy Cressey, Haseena Cassim, Jaime Deville, Gaerolwe Masheto, Ponego Ponatshego, Anne Coletti, Kathryn Lypen, Iris Mustich, Barbara Heckman, Mark Lojacono, Rachel Bowman, Dwight Yin, Ellen Townley, Sai Majji, Edward Acosta, Annie Buchanan, Cindy Brothers, Hardik Chandasana, Helena Rabie, Patricia Flynn, IMPAACT 2019 Team. Pharmacokinetics and Safety of Dispersible and Immediate Release FDC Abacavir/ Dolutegravir/ Lamivudine in Children with HIV Weighing =14 kg: Preliminary Results from IMPAACT 2019. Presented at: International Workshop on HIV Pediatrics; 2021 Jul 16.Conference
International Workshop on HIV Pediatrics
Study
IMPAACT 2019
Citation
Jeremiah Momper, Hardik Chandasana, Benjamin Johnston, Hannah Small, David Shapiro, Jiajia Wang, Evan Goldberg, Sarah Bradford, Iris Mustich, Haley Brozik, Dwight Yin, Ellen Townley, Kelly Colsh, Andrea McMunn, Gretchen Buckler, Annie Buchanan, Alicia Koblansky, Michael McKenna, Ceora Beijer, Helty Adisetiyo, Dean Soko, Mariam Aziz, Linda Aurpibul, Suchada Ruenglerdpong, Keswadee Lapphra, Kathleen Powis, Maria Letícia Cruz, Ed Acosta, Brookie Best, Mark Mirochnick, Diana Clarke. Pharmacokinetics and Safety of Dolutegravir in Neonates Exposed to HIV-1 (IMPAACT 2023). Presented at: International Workshop on HIV Pediatrics; 2024 Jul 20.Conference
International Workshop on HIV Pediatrics
Study
IMPAACT 2023
Citation
A Bekker, N Hanan, M Cababasay, J Wang, F Nakwa, E Smith, J Moye, A Violari, M Cotton, L Wiesner, J Norman, B Fourie, E Capparelli, M Mirochnick, P1106 Study Team. Pharmacokinetics and safety of lopinavir/ritonavir solution in HIV-infected newborns. Presented at: CROI 2018; 2018 Mar 05.Conference
CROI 2018
Study
P1106
Citation
FL Nakwa, A Bekker, A Violari, J Wang, M Cababasay, J Norman, M Cotton, M Mirochnick, E Capparelli, IMPAACT P1106 Study team. Pharmacokinetics and safety of trimethoprim-sulfamethoxazole in HIV-exposed low birth weight infants. Presented at: 37th Annual Meeting of the European Society for Paediatric Infectious Diseases.Conference
37th Annual Meeting of the European Society for Paediatric Infectious Diseases
Study
P1106
Citation
M Owor, C Tierney, L Ziemba, R Browning, J Moye, B Graham, C Reding, D Costello, J Norman, L Wiesner, E Hughes, M Whalen, L Purdue, BT Mmbaga, P Kamthunzi, R Kawalazira, K Nathoo, S Bradford, A Coletti, R Aweeka, P Musoke. Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092. Presented at: IAS 2019.Conference
IAS 2019
Study
P1092
Citation
Kathleen M. Powis, Mauricio Pinilla, Lauren Bergam, Alice Stek, Kristina M. Brooks, David Shapiro, Kevin Knowles, Kathleen George, Renee Browning, Nahida Chaktoura, James Rooney, Brookie M. Best, Mark Mirochnick, Jeremiah D. Momper, IMPAACT 2026 Protocol Team. Pharmacokinetics and Virologic Outcomes of Bictegravir in Pregnant and Postpartum Women with HIV. Presented at: CROI 2023.Conference
CROI 2023
Study
IMPAACT 2026
Citation
Richard Brundage, Pharm.D., Ph.D., Courtney V. Fletcher, Pharm.D., William D. Fiske, Ph.D., David Kornhauser, M.D., James McNamara, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Stuart E. Starr, M.D. Pharmacokinetics Of A Pediatric Efavirenz Suspension.Citation
J Momper, A Stek, J Wang, M Pinilla, D Shapiro, E Smith, N Chakhtoura, E Capparelli, M Mirochnick, B Best for the IMPAACT 1026s Protocol Team. Pharmacokinetics of Atazanavir Boosted with Cobicistat During Pregnancy and Postpartum. Presented at: 20th International Workshop on Clinical Pharmacology of HIV Hepatitis & Other Antiviral Drugs Conference.Conference
20th International Workshop on Clinical Pharmacology of HIV< Hepatitis & Other Antiviral Drugs Conference
Study
P1026S